Alcohol and the heart

Herz

Volumn 26, Issue 5, 2001, Pages 345-352

  Schoppet, Michael ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Alcohol; Alcohol serum markers; Atrial fibrillation; Cardiomyopathy; CDT

Indexed keywords

ALCOHOL CONSUMPTION; ALCOHOLIC CARDIOMYOPATHY; ALCOHOLISM; BLOOD CLOTTING; CARDIOTOXICITY; CHOLESTEROL BLOOD LEVEL; HEART ARRHYTHMIA; HEART DILATATION; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; REVIEW;

EID: 0034843897     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002037     Document Type: Review

References (84)

1. Alkohol und Herz
2. Alcoholic cardiomyopathy
3. The definition of alcoholism
4. A comparison of DSM-III-R, DSM-IV and ICD-10 substance use disorders diagnoses in 1922 men and women subjects in the COGA study
5. Cross-system agreement among demographic subgroups: DSM-III, DSM-III-R, DSM-IV and ICD-10 diagnoses of alcohol use disorders
6. Mechanisms of ethanol-induced cardiac damage
7. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
8. Alcoholic heart disease: A review
9. Alcohol and the cardiovascular system
10. Alcoholic cardiomyopathy
11. Report on the definition and classification of cardiomyopathies
12. Echocardiographic measurements in normal subjects from infancy to old age
13. Left ventricular size, mass and function in relation to the duration and quantity of heavy drinking in alcoholics
14. Prevalence and etiology of idiopathic dilated cardiomyopathy
15. Alcoholic cardiomyopathy
16. Prevalence of clinically occult cardiomyopathy in chronic alcoholism
17. Beriberi cardiomyopathy
18. The relation of alcoholic myopathy to cardiomyopathy
19. The effects of alcoholism on skeletal and cardiac muscle
20. Mechanism of myocardial contractile depression by clinical concentrations of ethanol. A study in ferret papillary muscles
21. Ethanol acutely and reversibly suppresses excitation-contraction coupling in cardiac myocytes
22. Effects of ethanol on the contractile function of the heart: A review
23. Acute effects of ethanol on cardiac function and intracellular calcium in perfused rat heart
24. Excitation-contraction coupling in rat myocardium: Alterations with long term ethanol consumption
25. Regulation of the mitochondrial ATP-synthase is defective in rat heart during alcohol-induced cardiomyopathy
26. Myocardial mechanical, biochemical, and structural alterations induced by chronic ethanol ingestion in rats
27. Effects of chronic graded ethanol consumption on the metabolism, ultrastructure, and mechanical function of the rat heart
28. Ethanol-induced inhibition of ventricular protein synthesis in vivo and the possible role of acetalclehyde
29. Changes in protein, RNA, and DNA and rates of protein synthesis in muscle-containing tissues of the mature rat in response to ethanol feeding: A comparative study of heart, small intestine and gastrocnemius muscle
30. Impaired myocardial protein synthesis induced by acute alcohol intoxication is associated with changes in eIF4F
31. Alcohol and the heart: Biochemical alterations
32. A comparative investigation into the effect of chronic alcohol feeding on the myocardium of normotensive and hypertensive rats: An electrophoretic and biochemical study
33. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes
34. The incidence of myocarditis in endomyocardial biopsy samples from patients with congestive heart failure
35. Alcohol and myocarditis
36. Reduction in circulating T lymphocytes in alcoholic liver disease
37. Alcohol (ethanol) inhibits IL-8 and TNF: Role of the p38 pathway
38. Alcohol abuse, alcoholism, and damage to the immune system - A review
39. What to advise patients about drinking alcohol: The clinician's conundrum
40. Is alcohol good for your health?
41. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction
42. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator
43. Fibrinogen. A possible link between alcohol consumption and cardiovascular disease?
44. Biphasic effects of repeated alcohol intake on 24-hour blood pressure in hypertensive patients
45. Acute ethanol ingestion modifies the circulating plasma levels of atrial natriuretic peptide
46. Effect of chronic ethanol consumption on the atrial natriuretic system of spontaneously hypertensive rats
47. Hypertension and alcohol: Central and peripheral mechanisms
48. Changes in cardiac sinal transduction systems in chronic ethanol treatment preceding the development of alcoholic cardiomyopathy
49. Arryhthmias and the "Holiday Heart": Alcohol-associated cardiac rhythm disorders
50. Long-term intracoronary ethanol administration electrophysiologic and morphologic effects
51. The "holiday heart": Electrophysiologic studies of alcohol effects in alcoholics
52. Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy
53. Nonsustained ventricular tachycardia in ambulatory patients: Characteristics and association with sudden cardiac death
54. Electrocardiographic abnormalities, conduction disorders and arrhythmias in primary myocardial disease
55. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
56. Dilated cardiomyopathies of the adult
57. Clinical and histologic features of alcohol drinkers with congestive heart failure
58. Myocarditis. A histopathologic definition and classification
59. Prediction of recovery after abstinence in alcoholic cardiomyopathy: Role of hemodynamic and morphometric parameters
60. Laboratory markers of alcoholism
61. Haemopoiesis and alcohol
62. Effect of acetaldehyde on hemoglobin: HbA1ach as a potential marker of heavy drinking
63. The SGOT/SGPT ratio - An indicator of alcoholic liver disease
64. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis
65. Environmental determinants, liver function, and high density lipoprotein cholesterol levels
66. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: A critical review of preanalysis, analysis, and interpretation
67. Objective diagnosis of alcohol abuse: Compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV)
68. Dose response of laboratory markers to alcohol consumption in a general population
69. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: A systemic review
70. Reversal of alcoholic cardiomyopathy in a patient with severe coronary artery disease
71. Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by ‴N monoclonal antimyosin antibodies
72. Molecular pathology of dilated cardiomyopathies
73. Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence
74. Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy
75. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy
76. The use of endomyocardial biopsies in heart failure
77. The natural history and spectrum of idiopathic dilated cardiomyopathy, including HIV and peripartum cardiomyopathy
78. Advances in development of medications for alcoholism treatment
79. Pharmacological treatment of alcohol dependence: A review of the evidence
80. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
81. A review of why and how we may use betablockers in congestive heart failure
82. Aldosterone and myocardial fibrosis in heart failure
83. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])
84. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias